IL1B and Hepatic failure: Therefore, the level of inflammatory factors (such as a high level of IL-1β) in liver failure patients can affect the efficacy of stem cells, but improving the inflammatory environment in liver failure patients prior to the application of stem cell therapy may improve the efficacy of stem cells.